Stroke is the most common cause of epilepsy and ultimately leads to a decrease in the
quality of life of those affected. Ischemic and hemorrhagic strokes can both lead to …

There are currently> 51 million people with epilepsy (PWE) in the world and every year> 4.9
million people develop new-onset epilepsy. The cornerstone of treatment in PWE is drug …

Futile recanalization remains a significant challenge for endovascular treatment (EVT) of
acute ischemic stroke (AIS). The inflammatory response that occurs after cerebral infarct …

The worsening of neurological status that occurs early after acute ischemic stroke (AIS)
remains a serious issue, and the inflammatory response plays a key role in stroke …

Background and purpose The management of post‐stroke epilepsy (PSE) should ideally
include prevention of both seizure and adverse effects; however, an optimal antiseizure …

Abstract Background and Purpose The progressive nature of epileptogenesis raises the
question of whether the latent period may already carry information about the characteristics …

Background and Objectives The functional outcome and mortality of patients with poststroke
epilepsy (PSE) have not been assessed in a prospective study. Previous reports have …

Poststroke epilepsy is a major ischaemic/haemorrhagic stroke complication. Seizure
recurrence risk estimation and early therapeutic intervention are critical, given the …

There is currently no evidence to support the use of antiseizure medications to prevent
unprovoked seizures following stroke. Experimental animal models suggested a potential …

Background Stroke is the most common cause of newly diagnosed epilepsy in the elderly,
ahead of degenerative disorders, brain tumors, and head trauma. Stroke accounts for 30 …